Top compounds associated with response to RP11-240B13.2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.0021 0.9
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.0022 1
mRNA UNC0321 CTRPv2 pan-cancer AAC -0.0021 1
mRNA ifosfamide CTRPv2 pan-cancer AAC -0.003 1
mRNA Platin CTRPv2 pan-cancer AAC -0.0019 1
mRNA KU-55933 CTRPv2 pan-cancer AAC 0.0018 1
mRNA C6-ceramide CTRPv2 pan-cancer AAC 0.0017 1
mRNA GSK525762A CTRPv2 pan-cancer AAC -0.0014 1
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC 0.0023 1
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC -0.0017 1
Download CSV